CTRI/2017/11/010615CompletedPhase 2
Add on effect of Shunthi Gokshura Kwath over Amavatari Rasa in Amavata with special reference to Rheumatoid Arthritis â?? A Randomised open clinical trial.
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 64
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Patients having classical features of Amavata (Angamarda, Aruchi, Trishna, Alasya, Gaurava, Jwara, Apaka, Shoonata anganam)
- •2. Patients having the Pratyatma lakshana of Amavata (Shotha, Sandhi ruja, Sandhi graha, Sarwanga / Ekanga Sandhi Sotha, Arati)
- •3. Pravriddha Lakshana of Amavata (Agni daurbalya, Praseka, Aruchi, Gaurava, Vairasya, Ruja and Shotha in Hasta, Pada, Shiro, Gulpha, Trika, Janu, Uru Sandhi, Vrishchika Danshavat Vedana, Kukshi kathinya, Kukshi shula, Vibandha, Anaha, Hritgraha, Antra kujana, Chhardi, Jadya, Bhrama, Murchcha, Nidra-Viparyaya, Daha, Bahumutrata)
- •4. ARA Criteria - Patients who have at least one joint with definite clinical synovitis (swelling) with the synovitis not better explained by another disease
Exclusion Criteria
- •1. Patients with other systemic complications of RA like RHD, Rheumatic fever, pleural â?? pericardial disease. Patients with poorly controlled Hypertension ( >160/100 mm of Hg)
- •2. Patients with Diabetes Mellitus (Fasting blood sugar more than 126 mg% and / or Post Prandial blood sugar more than 200 mg% OR HbA1c > 6.5%}
- •3. Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis etc.
- •4. Patients who are unable to walk without support and / or confined to wheel chair.
- •5. Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants, anticholinergic, etc. or any other drugs that may have an influence on the outcome of the study
- •6. Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •7. Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as Creatinine >1.2mg/Dl), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), or any other condition that may jeopardize the study.
- •8. Alcoholics and/or drug abusers.
- •9. H/o hypersensitivity to any of the trial drugs or their ingredients.
- •10. Pregnant / lactating woman.
- •11. Patients who have completed participation in any other clinical trial during the past 6 months.
Investigators
Similar Trials
Not yet recruiting
Phase 3
To Study the combine effect of Satwavjaya chikitsa with Guduchyadi Yog and only Guduchyadi Yog in management of Sthaulya (Obesity) w.s.r to Reduction in weight: A Randomized Controlled TrialCTRI/2023/10/058701Dr Leena Maroti Kapgate
Not yet recruiting
Phase 2
To see the effect of 2 medicines namely Dashmoola Amritadi Kwatha and Shallaki Guggulu in the treatment of disease Amavata(Rheumatoid Arthritis)CTRI/2019/09/021115Ayurvedic and Unani Tibbia College
Not yet recruiting
Not Applicable
TO STUDY THE EFFECT OF GOKSHUR PANEEYA KSHAR IN MANAGEMENT OF RENAL CALCULUSCTRI/2022/12/048476AKSHAY HEMADE
Not yet recruiting
Phase 2
To study the efficacy of Amalaki siddha Goghrita Aschyotana in the Management ofVernal KeratoconjunctivitisCTRI/2022/06/043356Dr Shruti Mohan Phadke
Not yet recruiting
Phase 2
Gokshuradi Guggulu With Musta Panaka as Anupana and Lodhra Vata Twaka Kashaya Yoni Prakshalana in Abnormal vaginal DischargeCTRI/2024/07/071280Government Ayurveda College and Hospital Tripunithura